Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-04 · accession 0001668397-24-000047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-06 | 2024-03-04+ | MEDP | Medpace Investors, LLC | 10% | S - Sale | $402.91 | -100.0K | 4.98M | -2% | -$40.29M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-05 | S | D | 50,000 | $402.70 | 4,933,019 | D | — | — | (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $404.39. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2024-03-04 | S | D | 50,000 | $403.12 | 4,983,019 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.52 to $408.21. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |